Should Levodopa Therapy for Parkinson's Disease Be Started Early or Late? Clinical Course of the Major Tetrad in 122 Parkinsonian Patients Treated With Levodopa Over 14 Years.

Japanese Journal of Medicine
doi 10.2169/internalmedicine1962.28.30
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Pharmacokinetics of Levodopa/Benserazide Versus Levodopa/Carbidopa in Healthy Subjects and Patients With Parkinson's Disease

Neurology and Clinical Neuroscience
Neurology
2014English

Sensory Tricks for Cervical Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease

Movement Disorders Clinical Practice
Neurology
2016English

Response of Non-Motor Symptoms to Levodopa in Late-Stage Parkinson's Disease: Results of a Levodopa Challenge Test

Parkinsonism and Related Disorders
GerontologyGeriatricsNeurology
2017English

Comparison of the Clinical Pharmacology of (-)NPA and Levodopa in Parkinson's Disease.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1991English

Levodopa Dosage and Ventilatory Function in Parkinson's Disease.

BMJ
1981English

Effect of Levodopa on Speech Dysfluency in Parkinson's Disease

Movement Disorders Clinical Practice
Neurology
2018English

Levodopa-Induced Dyskinesia in Parkinson's Disease: Sleep Matters

Annals of Neurology
Neurology
2018English

Clozapine for the Treatment of Levodopa and Dyskinesia in Parkinson's Disease

Irish Journal of Psychological Medicine
PsychiatryMental HealthPhilosophy of ScienceApplied PsychologyHistory
1995English

Multidisciplinary Care and the Reduction of Levodopa Intake of Patients With Advanced Parkinson's Disease

Acta Fisiátrica
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy